The historical rank and industry rank for PT Diagnos Laboratorium Utama Tbk's Pretax Margin % or its related term are showing as below:
ISX:DGNS's Pretax Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -3.56 * Ranked among companies with meaningful Pretax Margin % only.
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
PT Diagnos Laboratorium Utama Tbk Pretax Margin % Related Terms
PT Diagnos Laboratorium Utama Tbk Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diagnos Laboratorium Utama Tbk Pretax Margin % Chart
PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
Pretax Margin %
PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
Pretax Margin %
ISX:DGNS vs TMO, DHR, IDXX: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Diagnos Laboratorium Utama Tbk Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a Pretax Margin % of % as of . 20. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PT Diagnos Laboratorium Utama Tbk and its competitors. According to the industry distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 203 companies in the Medical Diagnostics & Research industry.
Is PT Diagnos Laboratorium Utama Tbk's Pretax Margin % too high?
PT Diagnos Laboratorium Utama Tbk's current Pretax Margin % is %. Based on the distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 203 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, PT Diagnos Laboratorium Utama Tbk has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does PT Diagnos Laboratorium Utama Tbk's Pretax Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 203 companies for Pretax Margin %. This places PT Diagnos Laboratorium Utama Tbk in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PT Diagnos Laboratorium Utama Tbk and its competitors. PT Diagnos Laboratorium Utama Tbk's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diagnos Laboratorium Utama Tbk stock overvalued right now?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a current Pretax Margin % of %. The current Pretax Margin % is %. PT Diagnos Laboratorium Utama Tbk's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For PT Diagnos Laboratorium Utama Tbk (ISX:DGNS), the current Pretax Margin % is % as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Diagnos Laboratorium Utama Tbk Business Description
PT Diagnos Laboratorium Utama Tbk operates in the field of Health Support Services and Private Clinic Activities. It provides health support service activities managed by both the government and the private sector, such as health laboratories in the form of X-Ray Laboratories, and other diagnostic imaging centers, as well as blood testing, private clinics, pharmaceutical warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other medical support services. Its products and services include Clinical Pathology Laboratory, Anatomical Pathology Laboratory, Genomics Laboratory, Homecare Health Services, Corporate Health Services, Microbiology Laboratory, and Research Services.
19GF Score
Get the complete analysis for ISX:DGNS
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DGNS has been successfully added to your 